|
|
| Animal Biotechnology - Technologies, Markets and Companies |
|
| Published : 2009/07 |
| This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage gene ... |
| Antiviral Therapeutics - technologies, markets and companies |
|
| Published : 2009/07 |
| This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their ... |
| Biomarkers - technologies,markets and companies |
|
| Published : 2009/07 |
| This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tes ... |
| Cardiovascular Drug Delivery - technologies,markets and companies |
|
| Published : 2009/07 |
| Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of the body. Drugs can be introduced into the vascular syste ... |
| Cell Therapy - Technologies, Markets and Companies |
|
| Published : 2009/07 |
| This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Ro ... |
| Cytogenetics - technologies,markets and companies |
|
| Published : 2009/07 |
| This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogeneti ... |
| DNA sequencing: technologies, markets and companies |
|
| Published : 2009/07 |
| This report briefly reviews development of sequencing technologies, current large and small sequencers as well as companies developing them. Companies developing software for analysis of sequencing data are listed. Selected academic institutes conducting ... |
| Drug Delivery in Cancer - technologies, markets and companies |
|
| Published : 2009/07 |
| Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. Cancer drug delivery is no longer sim ... |
| Gene Therapy - technologies, markets and companies |
|
| Published : 2009/07 |
| Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes and DNA are now being introduced without the use of ... |
| Molecular Diagnostics - Technologies, Markets and Companies |
|
| Published : 2009/07 |
| This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. ... |
| Nanobiotechnologies- applications, markets and companies |
|
| Published : 2009/07 |
| Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter. Nanobiotechnology, an integration of physical sciences, molecular engin ... |
| Neuroprotection - Drugs, Markets and Companies |
|
| Published : 2009/07 |
| This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues ... |
| Personalized Medicine - scientific & commercial aspects |
|
| Published : 2009/07 |
| The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concept ... |
| Proteomics - Technologies, Markets and Companies |
|
| Published : 2009/07 |
| This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century. Most commonly used technologi ... |
| RNAi - technologies, markets and companies |
|
| Published : 2009/07 |
| RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used in a sequence-specific manner to recognize and destroy ... |
| Transdermal Drug Delivery - Technologies, Markets, and Companies |
|
| Published : 2009/07 |
| This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are des ... |
| Accelerating Lead Generation: Emerging technologies and strategies |
|
| Published : 2009/06 |
| The number of approvals for new drugs and biologics has fallen steadily in recent years, despite increasing R&D expenditure. Cost effective and innovative approaches to drug discovery and development have therefore become particularly important to ensure ... |
| Bioinformatics and Computational Biology: Bottlenecks and Options |
|
| Published : 2009/06 |
| The interdisciplinary fields of Bioinformatics and Computational Biology are locked in a high stakes race with analytical instrument developers and innovators. The pace and scope of change in many fields of biomedical research rivals what we once associat ... |
| Biosimilars Series: Forecast Analysis |
|
| Published : 2009/06 |
| The high cost and utilization of biologic drugs, coupled to the growing need to curb pharmaceutical expenditure, provides considerable momentum to the emerging biosimilars market. With a biosimilar approval pathway in place in Europe and Japan, and immine ... |
| Clinical Bundle |
|
| Published : 2009/06 |
| The Clinical Bundle includes 4 reports within clinical laboratory analysis. ... |
| Clinical Chemistry Analyzers |
|
| Published : 2009/06 |
| Clinical chemistry analysis is one of the most important areas within clinical laboratory analysis. The term clinical chemistry usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small mol ... |
| Clinical Immunoanalyzer Markets |
|
| Published : 2009/06 |
| Clinical immunoanalyzer analysis is one of the most important functions of clinical laboratory analysis. By all accounts, automated immunoassay testing is the most rapidly developing of the traditional clinical laboratory sectors. Clinical immunoanalyzer ... |
| Genetics Bundle |
|
| Published : 2009/06 |
| The Clinical Bundle includes 8 reports based on the genetic markets. ... |
| Nucleic Acid Purification Dashboard, Series 2, June 2009 |
|
| Published : 2009/06 |
| Nucleic acid purification is one of the few basic methods ubiquitous among scientists using molecular biology techniques to investigate processes such as gene expression, genetic diversity, protein function and molecular interactions. ... |
| Pharmacogenomics for Clinical Use and in Drug Development |
|
| Published : 2009/06 |
| Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ... |
| Point of Care Diagnostic Testing Sector Trends |
|
| Published : 2009/06 |
| The purpose of this TriMark Publications report is to describe the sector trends within the point of care testing (POCT) diagnostic market. It examines those measurement devices and their reagents and supplies that are utilized in hospitals, clinics, comm ... |
| Point of Care Diagnostic Testing World Markets |
|
| Published : 2009/06 |
| The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT). It examines these clinical measurement devices and their reagents and supplies as utilized i ... |
| Stem Cell Markets |
|
| Published : 2009/06 |
| The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods tha ... |
| Synthetic Biology: Emerging Global Markets |
|
| Published : 2009/06 |
| The biotechnology and pharmaceuticals segment is the second-largest market segment, worth 80.3 million in 2008. This segment is projected to increase at a CAGR of 49.2% to reach $594 million in 2013. ... |
| Therapeutic Monoclonal Antibodies Markets |
|
| Published : 2009/06 |
| Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through re ... |
| Approaches to Reducing Phase II Attrition |
|
| Published : 2009/05 |
| Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving R&D productivity in the pharmaceutical and biotechnology industries and considers: ... |
| Asia Pacific Markets for Orthopedic Biomaterials 2009 |
|
| Published : 2009/05 |
| In 2008, the combined Asia Pacific Biomaterials market was worth $810.2 million. This study of the orthopedic biomaterials markets in Australia, Japan, South Korea and China covers autograft, bone graft substitutes (allograft, DBM and synthetic), hyaluron ... |
| Dealmaking and Industry Outlook: Antivirals |
|
| Published : 2009/05 |
| The infamous mutability of viruses has long challenged antiviral drug developers, but complete genome sequences are now known for thousands of viruses, and the viral proteins encoded in these sequences are being used as targets for novel antiviral develop ... |
| Strategic Analysis of the European Markets for Theranostics |
|
| Published : 2009/05 |
| This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported. ... |
| US Markets for ENT and Bronchoscopy Devices 2009 |
|
| Published : 2009/05 |
| The US markets for ear, nose, and throat (ENT) and bronchoscopy devices will grow moderately through 2013. The ENT market will be far larger than the market for bronchoscopy devices and will also expand more rapidly, reaching a value of more than $360 mil ... |
| Bone Grafts |
|
| Published : 2009/04 |
| This report analyzes the US market for Bone Grafts in Millions of US$. The market for Bone Grafts is analyzed by the following segments: Standard Allografts, Machined Bone Allografts, Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Plat ... |
| Capitalizing on New Opportunities for Stem Cell Products |
|
| Published : 2009/04 |
| Capitalizing on New Opportunities for Stem Cell Products provides a roadmap for stem cell product suppliers to help navigate a landscape that is poised for change- and growth. This analysis was designed to guide suppliers in redirecting resources to new a ... |
| Chinese Markets for Antibiotics |
|
| Published : 2009/04 |
| China' s demand for Antibiotics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply a ... |
| AgBiotech Reporter |
|
| Issues / Year : 24 |
| AgBiotech Reporter brings you all the very latest news, comment, analysis and trends in agricultural biotechnology. The qualitative and quantitative benefits brought by transgenic crops can help meet the ongoing challenges brought on by climate change and ... |
| BIOSIMILARS: BUSINESS REVIEW |
|
| Issues / Year : 4 |
| A quarterly review that will help you navigate through the twists and turns of the emerging biosimilar market. ... |
| Burrill Biotechnology Report Monthly |
|
| Issues / Year : 11 |
| The Burrill Biotechnology Report has the detailed market intelligence you need each month to obtain an accurate overview of all the latest global developments and trends. Our July launch issue will provide the 2008 half-year biotech report. This essential ... |
| Drug Delivery Insight |
|
| Issues / Year : 22 |
| This publication has regular coverage of global injection devices, infusion pumps, transdermal delivery, slow/controlled release and implantable and biotech related drug-delivery technology. ... |
| Futuretech Alert |
|
| Issues / Year : 18 |
| Futuretech watches hundreds of technologies in every research area including such diverse disciplines as nanotechnology, sensors, manufacturing, genetics, materials and coatings, microelectronics, and industrial bioprocessing. ... |
| GENETIC TECHNOLOGY ALERT |
|
| Issues / Year : 51 |
| This newsletter presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions ... |
| Industrial Bioprocessing |
|
| Issues / Year : 51 |
| Industrial Bioprocessing provides you with the latest intelligence in the industrial bioprocessing field, including new processes to develop specialty chemicals, pharmaceuticals, alternative fuels, and chemical feedstocks ... |
| Stem Cell News |
|
|
| These days we all suffer from information overload. To overcome this problem, the Stem Cell News service focuses specifically on stem cell research, delivering the information you need in a timely, flexible and convenient format. ... |
| Biomedical IndustryAnalyzer |
|
|
| During 2004, the top fifty pharmaceutical companies issued over 2400 press releases. These press releases announced deals and alliances, drug development milestones, new patents, management changes, financings, and financial results. ... |
| Biomedical Smart Reports: Industry Background Reports |
|
|
| The Industry Background Reports are designed to provide a Comprehensive list of all companies with any involvement in the specific disease or technology, while, at the same time, presenting all current news issued by those companies, and all current news ... |
|
|
Top
View Cart